• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过抗体竞争检测P-糖蛋白构象变化

P-Glycoprotein conformational changes detected by antibody competition.

作者信息

Nagy H, Goda K, Arceci R, Cianfriglia M, Mechetner E, Szabó G

机构信息

Department of Biophysics and Cell Biology, University of Debrecen, Hungary.

出版信息

Eur J Biochem. 2001 Apr;268(8):2416-20. doi: 10.1046/j.1432-1327.2001.02122.x.

DOI:10.1046/j.1432-1327.2001.02122.x
PMID:11298761
Abstract

Conformational changes accompanying P-glycoprotein (Pgp) mediated drug transport are reflected by changes in the avidity of certain monoclonal antibodies (mAbs). More of the UIC2 mAb binds to Pgp-expressing cells in the presence of substrates or modulators [Mechetner, E.B., Schott, B., Morse, S.B., Stein, W., Druley, T., Dvis, K.A., Tsuruo, T. & Roninson, I.B. (1997) Proc. Natl Acad. Sci. USA 94, 12908-12913], while the binding of other mAbs (e.g. MM12.10, MRK16, 4E3) is not conformation sensitive. Pre-staining of Pgp+ cells with UIC2 decreased the subsequent binding of MM12.10 mAb by about 30-40%, suggesting that there are Pgp molecules available for both UIC2 and MM12.10, and others accessible only for MM12.10. In the presence of certain substrates/modulators such as vinblastin, cyclosporin A or valinomycin, the MM12.10 reactivity was completely abolished by preincubation with UIC2. However, verapamil, Tween-80 and nifedipine did not influence the ratio of bound mAbs significantly. This is the first assay to our knowledge, sharply distinguishing two classes of modulators. The conformational changes accompanying the mAb competition phenomenon appear to be closely related, though not identical to those accompanying the UIC2-shift, as suggested by the simultaneous assessment of the two phenomena.

摘要

某些单克隆抗体(mAb)亲和力的变化反映了与P-糖蛋白(Pgp)介导的药物转运相关的构象变化。在存在底物或调节剂的情况下,更多的UIC2单克隆抗体与表达Pgp的细胞结合[Mechetner, E.B., Schott, B., Morse, S.B., Stein, W., Druley, T., Dvis, K.A., Tsuruo, T. & Roninson, I.B. (1997) Proc. Natl Acad. Sci. USA 94, 12908-12913],而其他单克隆抗体(如MM12.10、MRK16、4E3)的结合对构象不敏感。用UIC2对Pgp+细胞进行预染色可使MM12.10单克隆抗体随后的结合减少约30-40%,这表明存在可供UIC2和MM12.10结合的Pgp分子,以及仅可供MM12.10结合的其他分子。在存在某些底物/调节剂(如长春碱、环孢素A或缬氨霉素)的情况下,与UIC2预孵育可完全消除MM12.10的反应性。然而,维拉帕米、吐温-80和硝苯地平对结合的单克隆抗体比例没有显著影响。据我们所知,这是第一个能清晰区分两类调节剂的检测方法。如对这两种现象的同时评估所示,伴随单克隆抗体竞争现象的构象变化似乎密切相关,尽管与伴随UIC2位移的构象变化并不完全相同。

相似文献

1
P-Glycoprotein conformational changes detected by antibody competition.通过抗体竞争检测P-糖蛋白构象变化
Eur J Biochem. 2001 Apr;268(8):2416-20. doi: 10.1046/j.1432-1327.2001.02122.x.
2
Effects of ATP depletion and phosphate analogues on P-glycoprotein conformation in live cells.ATP 耗竭和磷酸盐类似物对活细胞中 P-糖蛋白构象的影响。
Eur J Biochem. 2002 Jun;269(11):2672-7. doi: 10.1046/j.1432-1033.2002.02929.x.
3
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.多药耐药调节因子的不同组可通过P-糖蛋白特异性抗体的竞争来区分。
Biochem Biophys Res Commun. 2004 Mar 19;315(4):942-9. doi: 10.1016/j.bbrc.2004.01.156.
4
P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation.不同细胞系中P-糖蛋白介导的秋水仙碱耐药性与秋水仙碱对P-糖蛋白构象的影响相关。
Biochemistry. 2001 Apr 10;40(14):4323-31. doi: 10.1021/bi001372n.
5
Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation.人P-糖蛋白的变构调节。通过阻止底物转运和解离来抑制转运。
J Biol Chem. 2003 May 16;278(20):18132-9. doi: 10.1074/jbc.M210413200. Epub 2003 Mar 17.
6
Cholesterol-dependent conformational changes of P-glycoprotein are detected by the 15D3 monoclonal antibody.P-糖蛋白的胆固醇依赖性构象变化可通过15D3单克隆抗体检测到。
Biochim Biophys Acta. 2016 Mar;1861(3):188-95. doi: 10.1016/j.bbalip.2015.12.007. Epub 2015 Dec 15.
7
Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity.利用差异免疫反应性分析通透细胞中MDR1 P-糖蛋白的构象变化。
Biochemistry. 2001 Apr 10;40(14):4312-22. doi: 10.1021/bi001371v.
8
Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.多药转运蛋白P-糖蛋白功能改变突变体中耐药性与药物诱导构象转变的协同变化。
Biochemistry. 2001 Apr 10;40(14):4332-9. doi: 10.1021/bi001373f.
9
The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity.UIC2单克隆抗体强大的体内抗肿瘤作用是Pgp抑制和抗体依赖性细胞介导的细胞毒性共同作用的结果。
PLoS One. 2014 Sep 19;9(9):e107875. doi: 10.1371/journal.pone.0107875. eCollection 2014.
10
P-glycoprotein function involves conformational transitions detectable by differential immunoreactivity.P-糖蛋白的功能涉及可通过差异免疫反应性检测到的构象转变。
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12908-13. doi: 10.1073/pnas.94.24.12908.

引用本文的文献

1
Synergistic Inhibitory Effect of Quercetin and Cyanidin-3O-Sophoroside on ABCB1.槲皮素和矢车菊素-3-O-槐糖苷对 ABCB1 的协同抑制作用。
Int J Mol Sci. 2023 Jul 12;24(14):11341. doi: 10.3390/ijms241411341.
2
Effects of Polyphenols on P-Glycoprotein (ABCB1) Activity.多酚对P-糖蛋白(ABCB1)活性的影响。
Pharmaceutics. 2021 Dec 2;13(12):2062. doi: 10.3390/pharmaceutics13122062.
3
Human ABCB1 with an ABCB11-like degenerate nucleotide binding site maintains transport activity by avoiding nucleotide occlusion.具有 ABCB11 样退化核苷酸结合位点的人 ABCB1 通过避免核苷酸封闭来维持转运活性。
PLoS Genet. 2020 Oct 8;16(10):e1009016. doi: 10.1371/journal.pgen.1009016. eCollection 2020 Oct.
4
Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells.冠醚逆转肿瘤细胞中 P-糖蛋白介导的多药耐药性。
Sci Rep. 2018 Sep 27;8(1):14467. doi: 10.1038/s41598-018-32770-y.
5
Binding Performance of Human Intravenous Immunoglobulin and 20()-7-Ethylcamptothecin.人血丙种球蛋白与喜树碱 20(S)-7-乙基醚的结合性能。
Molecules. 2018 Sep 18;23(9):2389. doi: 10.3390/molecules23092389.
6
Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.通过流式细胞术多药耐药检测预测白血病的治疗反应和预后
EJIFCC. 2013 Jan 16;23(4):117-23. eCollection 2013 Jan.
7
Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.维拉帕米与结合于外排转运体P-糖蛋白的ATP之间的协同作用。
Biochem Pharmacol. 2016 Oct 15;118:96-108. doi: 10.1016/j.bcp.2016.08.013. Epub 2016 Aug 13.
8
Crystal structure of the antigen-binding fragment of a monoclonal antibody specific for the multidrug-resistance-linked ABC transporter human P-glycoprotein.一种针对与多药耐药相关的ABC转运蛋白人P-糖蛋白的单克隆抗体抗原结合片段的晶体结构。
Acta Crystallogr F Struct Biol Commun. 2016 Aug;72(Pt 8):636-41. doi: 10.1107/S2053230X16009778. Epub 2016 Jul 27.
9
Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.解析心血管药物维拉帕米和地高辛与P-糖蛋白之间复杂的药物相互作用。
Biosci Rep. 2016 Jan 28;36(2):e00309. doi: 10.1042/BSR20150317.
10
The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein--a well-known, yet poorly understood drug transporter.分子对接技术解析与P-糖蛋白相关争议和挑战的能力——P-糖蛋白是一种广为人知但却了解甚少的药物转运蛋白。
Invest New Drugs. 2014 Aug;32(4):618-25. doi: 10.1007/s10637-014-0098-1. Epub 2014 Apr 22.